Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Review of the Eprinomectin effective doses required for dairy goats: Where do we go from here?

Abstract : Eprinomectin (EPM) has been recently granted a marketing authorisation in the European Union for use in goats, with a zero-day milk withdrawal period. Considering the high prevalence of benzimidazole resistance worldwide and the economic implications of managing milk residues, EPM may today be considered the main (or even the only) affordable treatment option, at least in dairy goats in the EU. However, the chosen dose (1 mg/kg) seems to be suboptimal, especially for lactating goats, and the chosen route of administration (Pour-on) highly subject to inter-individual variability. Considering the scarcity of anthelmintic resources, such a dosage regimen might threat the sustainability of this crucial drug in goat milk production and needs to be urgently discussed and reassessed.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.inrae.fr/hal-02922031
Déposant : Michel Leroux <>
Soumis le : mardi 25 août 2020 - 17:07:32
Dernière modification le : mercredi 26 août 2020 - 03:23:38

Lien texte intégral

Identifiants

Collections

Citation

Antoine Rostang, Jacques Devos, Christophe Chartier. Review of the Eprinomectin effective doses required for dairy goats: Where do we go from here?. Veterinary Parasitology, Elsevier, 2020, 277, pp.108992. ⟨10.1016/j.vetpar.2019.108992⟩. ⟨hal-02922031⟩

Partager

Métriques

Consultations de la notice

8